Clinical Trials Logo

Filter by:
NCT ID: NCT00319618 Completed - Clinical trials for Metastatic Breast Cancer

Combination Weekly Taxotere™ With Iressa™ /Placebo in Metastatic Breast Cancer

Start date: June 2003
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine if combination therapy of weekly Taxotere™ with Iressa™ will increase the objective responses in measurable leasions in metastatic breast cancer

NCT ID: NCT00319540 Completed - Unipolar Depression Clinical Trials

RCT of Psychoeducational Program of Depression

Start date: March 2001
Phase: Phase 2
Study type: Interventional

The purpose of the study is to test the efficacy of a psychoeducational group program on unipolar depression

NCT ID: NCT00319423 Completed - Hip Osteoarthritis Clinical Trials

Exercise Therapy and Patient Education for Individuals With Hip Osteoarthritis. a RCT.

Start date: April 2005
Phase: N/A
Study type: Interventional

Aims: 1. Evaluate the effect of an exercise therapy program and patient education, versus patient education only, on hip function among patients with radiologically verified hip OA 2. To identify biomechanical differences during gait, one-leg standing , and two-legged-raise analysis in patients with hip OA following either exercise therapy and patient education program, or a patient education program only. Main Hypothesis: Significant improved hip function (WOMAC) will be demonstrated in patients with hip osteoarthritis (OA) (radiographically verified hip OA) following a patient education program and a 12 week exercise therapy program, compared to those only going through a patient education program. Material and Methods: 110 patients with radiographically verified hip OA will be included in the randomized controlled trial; they will be randomized into: 1. Patient Education, or 2. Patient Education in addition to a supervised exercise program. The main outcome is: The Disease Specific WOMAC-Index. Secondary outcome measures are: SF-36v2 (quality of life),PASE (activity score), Self-efficacy for pain, muscle strength tests, gait analysis (biomechanical analysis),6 minutes walking test, Åstrand's bike test, range of motion. Status: The PhD student is accepted at the University of Oslo,and the study has so far included 17 subjects. The study will be carried out: NAR-Orthopedic Centre, Ullevaal University Hospital in collaboration with Diakonhjemmet Hospital and University of Delaware. The study is included in our research program for active rehabilitation.

NCT ID: NCT00319189 Completed - Clinical trials for Renal Transplant Recipients

Efficacy and Safety of Nateglinide Treatment in Renal Transplant Recipients

Start date: November 2002
Phase: Phase 4
Study type: Interventional

The objective of the present study is to evaluate both the efficacy and safet of nateglinide in renal transplanta recipients with posttransplant diabetes mellitus or impaired glucose tolerance. Primarily will the change in glucose tolerance and acute insuline responce be addressed.

NCT ID: NCT00319124 Completed - Hip Osteoarthritis Clinical Trials

Exercise Therapy and Patient Education for Individuals With Hip Osteoarthritis of the Hip. A Case-Control Study

Start date: April 2005
Phase: N/A
Study type: Observational

To identify differences between patients with OA of the hip in an early stage and a healthy control group. Hypothesis 1.1 There are significant differences between patients with OA of the hip in an early stage and a healthy control group in terms of functional capacity, biomechanical / kinematic variables, muscle strength and range of motion. Osteoarthritis (OA) is by far the most prevalent joint disorder today. The knee and the hip are large joints to be targeted and is an important cause of pain and disability. In knee OA, it is shown that significant risk factors in developing the disease are quadriceps weakness, joint instability, and changes in joint loading. A few studies on hip OA have shown altered gait pattern, which affect joint loading, and one study has shown weakness in abductors, adductors and flexors around the hip. As joint loading and muscle weakness are important factors in the development in knee OA, it might as well be factors influencing OA in the hip. The purpose of this case-control studies was to compare hip OA patients to a healthy control group regarding biomechanical and clinical differences. Patients with hip pain, activity limitations (Harris Hip Score 60-95 p) and radiographically verified hip OA was included. The healthy control group will have a Harris Hip Score of 100 p. One hundred and ten patients and fifty controls will be asked to fill in questionnaires on pain, stiffness and physical function (WOMAC), quality-of-life (SF-36 v2), self-efficacy (Lorigue), and activity (PASE) in addition to perform 6-minute walk test, sub-maximal cardiovascular function, strength, and hip range of motion tests. Additionally, Qualisys Pro reflex 3D motion analysis system will be used during walking, one-leg standing, and raising from a chair on a sub-group of 40 patients and 20 controls.

NCT ID: NCT00318825 Completed - Pain Clinical Trials

Nitrous Oxide for Analgesia During Colonoscopy

Start date: April 2006
Phase: Phase 4
Study type: Interventional

The purpose of the study is to determine the analgetic effect of nitrous oxide during colonoscopy, compared to no sedation and intravenous (IV) sedation.

NCT ID: NCT00318461 Completed - Clinical trials for Diabetes Mellitus, Type 2

To Compare the Effect of Liraglutide When Given Together With Metformin With the Effect of Metformin Given Alone and With the Effect of Glimepiride and Metformin Given Together

LEAD-2
Start date: May 2006
Phase: Phase 3
Study type: Interventional

This trial is conducted in Europe, Oceania, Africa, Asia and South America. This trial is designed to show the effect of treatment with liraglutide when adding to existing metformin therapy and to compare it with the effects of metformin monotherapy and combination therapy of metformin and glimepiride. Two trial periods: A 6 month (26 weeks) randomised, double-blinded period followed by an 18 months open-label extension, in total 2 years (104 weeks).

NCT ID: NCT00317265 Terminated - Clinical trials for Coronary Artery Disease

Coronary Bypass Surgery Trial: Complete Arterial Revascularization and Conventional Coronary Artery Surgery

Start date: January 1999
Phase: N/A
Study type: Interventional

This is a randomized, prospective European Multicenter Study comparing complete arterial revascularization of the coronary arteries using arterial graft material exclusively and “conventional” coronary artery bypass surgery using the left internal thoracic artery as graft to the left anterior descending artery (LAD) and vein grafts to other vessels to be bypassed.

NCT ID: NCT00314860 Completed - Clinical trials for Restless Legs Syndrome

RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole

Start date: February 2006
Phase: Phase 3
Study type: Interventional

Restless Legs Syndrome (RLS) study in adults comparing immediate release ropinirole with extended release ropinirole over 12 weeks

NCT ID: NCT00314392 Completed - Experimental Pain Clinical Trials

Gender, Pain, and Placebo Analgesia

Start date: September 2006
Phase: N/A
Study type: Interventional

The response to standard pain stimuli in males and females is investigated, together with the effect of informing participants about the effect of a painkiller. Physiological response to pain is recorded.